Company Filing History:
Years Active: 2025
Title: David Graber: Innovator in Neurodegenerative Disease Treatment
Introduction
David Graber is a prominent inventor based in Hanover, NH (US). He has made significant contributions to the field of medical science, particularly in the treatment of neurodegenerative diseases. His innovative work focuses on developing novel therapeutic approaches that harness the power of modified regulatory T cells.
Latest Patents
David Graber holds a patent for "Chimeric antigen receptors for treatment of neurodegenerative diseases and disorders." This patent describes novel chimeric antigen receptors (CARs) and modified regulatory T cells (Tregs) that express these CARs. The invention aims to prevent oxidative and inflammatory activity while promoting neuronal growth and survival. The compositions and methods outlined in the patent are designed to treat and prevent neurodegenerative diseases, particularly in individuals at risk due to genetic factors or those showing early signs of such diseases. He has 1 patent to his name.
Career Highlights
Graber is affiliated with Dartmouth College, where he conducts research and collaborates with other experts in the field. His work has garnered attention for its potential to revolutionize treatment options for patients suffering from neurodegenerative conditions.
Collaborations
Some of his notable coworkers include Charles L Sentman and W James Cook. Their collaborative efforts contribute to advancing research in the area of neurodegenerative diseases.
Conclusion
David Graber's innovative work in developing chimeric antigen receptors represents a significant advancement in the treatment of neurodegenerative diseases. His contributions to medical science continue to inspire future research and therapeutic strategies.